IRIS
VITALE, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.337
EU - Europa 7.639
AS - Asia 3.318
SA - Sud America 703
AF - Africa 61
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 15
Totale 28.113
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.260
RU - Federazione Russa 2.446
UA - Ucraina 1.529
CN - Cina 1.150
SG - Singapore 945
VN - Vietnam 939
GB - Regno Unito 744
IT - Italia 695
SE - Svezia 674
DE - Germania 635
BR - Brasile 604
FR - Francia 498
FI - Finlandia 142
HK - Hong Kong 70
NL - Olanda 70
PL - Polonia 50
AR - Argentina 43
EU - Europa 39
IN - India 36
CA - Canada 35
JP - Giappone 33
IE - Irlanda 27
MX - Messico 24
BD - Bangladesh 23
ZA - Sudafrica 20
BE - Belgio 19
IQ - Iraq 19
AT - Austria 17
EC - Ecuador 17
ES - Italia 15
ID - Indonesia 14
LV - Lettonia 14
MA - Marocco 13
AU - Australia 12
PK - Pakistan 11
TR - Turchia 11
CL - Cile 10
TN - Tunisia 7
VE - Venezuela 7
AZ - Azerbaigian 6
CO - Colombia 6
CZ - Repubblica Ceca 6
ET - Etiopia 6
GR - Grecia 6
KZ - Kazakistan 6
PT - Portogallo 6
PY - Paraguay 6
SA - Arabia Saudita 6
BG - Bulgaria 5
CR - Costa Rica 5
IR - Iran 5
KR - Corea 5
LU - Lussemburgo 5
UZ - Uzbekistan 5
BO - Bolivia 4
CH - Svizzera 4
DK - Danimarca 4
LT - Lituania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
DZ - Algeria 3
HR - Croazia 3
JO - Giordania 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
EG - Egitto 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
RO - Romania 2
SO - Somalia 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LY - Libia 1
MC - Monaco 1
Totale 28.095
Salva come PNG Salva come JPEG
Città #
Fairfield 2.107
Woodbridge 1.882
Houston 1.679
Ann Arbor 1.318
Dallas 1.106
Wilmington 1.054
Ashburn 991
Chandler 897
Seattle 840
Dong Ket 774
Cambridge 689
Dearborn 535
Nyköping 441
Jacksonville 427
Shenzhen 396
Southend 392
Moscow 380
Beijing 306
Boardman 283
Singapore 264
Lawrence 152
Princeton 151
Ogden 108
Shanghai 108
New York 99
The Dalles 98
Naples 87
San Diego 74
Grafing 69
Hong Kong 69
Los Angeles 68
Norwalk 63
Düsseldorf 62
Ho Chi Minh City 60
London 54
Des Moines 49
Groningen 49
Rome 44
Yubileyny 44
Munich 43
São Paulo 43
Hanoi 42
Falls Church 39
Chicago 37
Nanjing 36
Kraków 34
Jinan 31
Santa Clara 30
Columbus 26
Dublin 26
Rio de Janeiro 24
Bergamo 22
Shenyang 22
Milan 20
Hefei 19
Napoli 19
Tokyo 19
Brussels 18
Nanchang 18
Edinburgh 17
Toledo 16
Auburn Hills 15
Redwood City 15
Boston 14
Bremen 14
Kunming 14
Riga 14
Belo Horizonte 13
Helsinki 13
Salt Lake City 13
Warsaw 13
Washington 13
Brasília 12
Curitiba 12
Frankfurt am Main 12
Kilburn 12
Montreal 12
Vienna 12
Amsterdam 11
Florence 11
Stockholm 11
Da Nang 10
Guangzhou 10
Guayaquil 10
Lauterbourg 10
New Bedfont 10
Zhengzhou 10
Changsha 9
Haiphong 9
Tampa 9
Tappahannock 9
Toronto 9
Bari 8
Brooklyn 8
Hangzhou 8
Hebei 8
Johannesburg 8
Matawan 8
Miami 8
Ningbo 8
Totale 19.295
Salva come PNG Salva come JPEG
Nome #
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy 613
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. 297
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 291
Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study 289
Reliability and validity of Italian version of the Dimensional Apathy Scale in Parkinson’s Disease 287
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale 266
Apathy and related Executive Syndromes in Dementia associated with Parkinson’s Disease and in Alzheimer’s Disease 266
Hearing Impairment in Parkinson’s Disease: Expanding the Non-Motor Phenotype 262
Abnormal eating behaviors in progressive supranuclear palsy 258
Cognitive and affective theory of mind in patients with essential tremor 258
Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients 255
Apathy in Parkinson’s Disease: diagnosis, neuropsychological correlates, pathophysiology and treatment 249
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 246
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 244
Affective theory of mind in patients with Parkinson's disease: comment 238
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients 237
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 232
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 231
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations 231
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients 231
Impact of cognitive tasks on kinematic gait parameters in FTD patients 230
Effects of physical rehabilitation on gait pattern in parkinsonian patients with lateral trunk flexion: a three dimensional motion analysis investigation 229
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 229
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 229
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions 227
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia 222
Apoptotic mechanisms in mutant LRRK2-mediated cell death 221
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 218
Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients 217
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease 216
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 215
Parkinson’s patients with or without MCI classified according to wavelet analysis of lower limb joint angles in gait cycle 214
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 213
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 213
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease 211
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease 210
The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease 209
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients 208
Gender and non motor fluctuations in Parkinson's disease: a prospective study 207
Pathological gambling in Parkinson's disease. A comprehensive review 206
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 206
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 204
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients 203
How does smoking affect olfaction in Parkinson's disease? 203
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 203
The "eye of the tiger" sign in pure akinesia with gait freezing 200
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. 200
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 197
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 197
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 197
Season of birth and Parkinson's disease: possible relationship? 196
Electrophysiological comparison between males and females in HNPP 195
Cervico-oculo-Acoustic syndrome in a male with consanguineous parents 195
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages 194
Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait 193
Teaching NeuroImages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 193
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy 193
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 192
Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? 192
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 192
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 189
Gender and non motor fluctuations in Parkinson's disease: A prospective study 189
Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. 189
Cognitive dysfunctions in occipital lobe epilepsy compared to temporal lobe epilepsy. 189
Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment 188
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2 187
A (single case) rehabilitation program based on cueing for freezing of speech 186
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. 186
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease 186
Neuropsychological profile of adult patients with non symptomatic occipital lobe epilepsies 185
The closing-in phenomenon in Parkinson's disease 185
Early MRI findings in Acquired hepatocerebral degeneration 183
Comment on Poletti et al. “Affective theory of mind in patients with Parkinson's disease”. 182
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 182
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 180
Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease 180
Uric acid relates to dopamine transporter availability in Parkinson's disease 179
Normative data for the Montreal Cognitive Assessment in an Italian population sample 179
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 179
Linkage exclusion in Italian families with hereditary essential tremor 177
Impulse Control Disorders induced by Rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 Cases 177
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 177
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 175
Hemi-Restless Legs Syndrome induced by Clebopride 174
The relationship between cerebral vascular disease and parkinsonism: the VADO study 174
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 173
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 172
Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson’s Disease 171
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease 170
Link between non-motor symptoms and cognitive dysfunctions in de-novo, drug naïve PD patients 169
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients 168
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease 168
Using gait analysis' parameters to classify Parkinsonism: A data mining approach 168
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study 166
Hearing impairment in Parkinson’s disease: expanding non motor phenotype 164
Cognitive correlates of “pure apathy” in Parkinson's disease 163
The role of Vitamin D levels on neuropsychological profile of patients with Parkinson’s Disease 162
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study. 162
Ping-pong gaze: Sherrington would not have done it better 161
Mild Cognitive Impairment in drug-naïve PD patients is associated with cerebral hypometabolism 161
Totale 20.825
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.898 0 0 0 0 0 105 337 39 148 241 136 892
2021/20221.528 189 151 44 402 84 102 163 120 98 95 50 30
2022/20232.611 310 164 143 315 236 436 106 312 312 75 150 52
2023/20241.229 91 44 449 46 26 106 32 81 171 61 18 104
2024/20254.479 61 360 26 109 96 401 1.121 1.358 336 238 206 167
2025/20262.799 377 863 793 480 224 62 0 0 0 0 0 0
Totale 28.404